286 related articles for article (PubMed ID: 10341400)
1. Nuchal translucency in fetuses affected by homozygous alpha-thalassemia-1 at 12-13 weeks of gestation.
Lam YH; Tang MH; Lee CP; Tse HY
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):238-40. PubMed ID: 10341400
[TBL] [Abstract][Full Text] [Related]
2. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
[TBL] [Abstract][Full Text] [Related]
3. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
[TBL] [Abstract][Full Text] [Related]
4. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
[TBL] [Abstract][Full Text] [Related]
5. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance.
Bilardo CM; Müller MA; Pajkrt E; Clur SA; van Zalen MM; Bijlsma EK
Ultrasound Obstet Gynecol; 2007 Jul; 30(1):11-8. PubMed ID: 17559183
[TBL] [Abstract][Full Text] [Related]
6. Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester?
Spencer K; Bindra R; Nix AB; Heath V; Nicolaides KH
Ultrasound Obstet Gynecol; 2003 Aug; 22(2):142-8. PubMed ID: 12905507
[TBL] [Abstract][Full Text] [Related]
7. Prenatal diagnosis of β-thalassemia: nuchal translucency in affected fetuses.
Di Fraja D; Sarno L; Migliucci A; Acampora E; Napolitano R; Maruotti GM; Martinelli P
Minerva Ginecol; 2011 Dec; 63(6):491-4. PubMed ID: 22036753
[TBL] [Abstract][Full Text] [Related]
8. Human chorionic gonadotropin and plasma protein-A in alpha0-thalassemia pregnancies.
Ong CY; Lee CP; Leung KY; Lau E; Tang MH
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):651-5. PubMed ID: 16946227
[TBL] [Abstract][Full Text] [Related]
9. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
[TBL] [Abstract][Full Text] [Related]
10. The effect of fetal gender on nuchal translucency at 10-14 weeks of gestation.
Lam YH; Tang MH; Lee CP; Sin SY; Tang R; Wong HS; Wong SF
Prenat Diagn; 2001 Aug; 21(8):627-9. PubMed ID: 11536259
[TBL] [Abstract][Full Text] [Related]
11. Preliminary normal reference values of nuchal translucency thickness in Taiwanese fetuses at 11-14 weeks of gestation.
Hsu JJ; Hsieh CC; Chiang CH; Lo LM; Hsieh TT
Chang Gung Med J; 2003 Jan; 26(1):12-9. PubMed ID: 12656304
[TBL] [Abstract][Full Text] [Related]
12. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology.
Haak MC; Bartelings MM; Gittenberger-De Groot AC; Van Vugt JM
Ultrasound Obstet Gynecol; 2002 Jul; 20(1):14-21. PubMed ID: 12100412
[TBL] [Abstract][Full Text] [Related]
13. Ductus venosus Doppler study in fetuses with homozygous alpha-thalassemia-1 at 12 to 13 weeks of gestation.
Lam YH; Tang MH; Tse HY
Ultrasound Obstet Gynecol; 2001 Jan; 17(1):30-3. PubMed ID: 11244652
[TBL] [Abstract][Full Text] [Related]
14. Jugular lymphatic sacs in first-trimester fetuses with normal nuchal translucency.
de Mooij YM; Bekker MN; Spreeuwenberg MD; van Vugt JM
Ultrasound Obstet Gynecol; 2009 Apr; 33(4):394-8. PubMed ID: 19248150
[TBL] [Abstract][Full Text] [Related]
15. The distribution of nuchal translucency at 10-13 weeks of pregnancy.
Schuchter K; Wald N; Hackshaw AK; Hafner E; Liebhart E
Prenat Diagn; 1998 Mar; 18(3):281-6. PubMed ID: 9556045
[TBL] [Abstract][Full Text] [Related]
16. Changes in nuchal translucency thickness in normal and abnormal karyotype fetuses.
Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C; Monni G
BJOG; 2003 Jun; 110(6):584-8. PubMed ID: 12798476
[TBL] [Abstract][Full Text] [Related]
17. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses.
Michailidis GD; Economides DL
Ultrasound Obstet Gynecol; 2001 Feb; 17(2):102-5. PubMed ID: 11251915
[TBL] [Abstract][Full Text] [Related]
18. Disappearance of enlarged nuchal translucency before 14 weeks' gestation: relationship with chromosomal abnormalities and pregnancy outcome.
Müller MA; Pajkrt E; Bleker OP; Bonsel GJ; Bilardo CM
Ultrasound Obstet Gynecol; 2004 Aug; 24(2):169-74. PubMed ID: 15287055
[TBL] [Abstract][Full Text] [Related]
19. Association between fetal nuchal translucency thickness in first trimester and subsequent gestational hypertension and preeclampsia.
Tsai MS; Lee FK; Cheng CC; Hwa KY; Cheong ML; She BQ
Prenat Diagn; 2002 Sep; 22(9):747-51. PubMed ID: 12224064
[TBL] [Abstract][Full Text] [Related]
20. Relationship between fetal nuchal translucency and crown-rump length in an Asian population.
Jou HJ; Wu SC; Li TC; Hsu HC; Tzeng CY; Hsieh FJ
Ultrasound Obstet Gynecol; 2001 Feb; 17(2):111-4. PubMed ID: 11251917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
